Leiomyoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2021-07-09
EMA Withdrawn: Ulipristal Acetate Gedeon Richter (ulipristal acetate) — Gedeon Richter Plc.
EMA withdrawal of Ulipristal Acetate from Gedeon Richter for leiomyoma.